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ABSTRACT
Visceral leishmaniasis, associated with HIV/AIDS coinfection, is becoming a more 
aggressive disease, complicating an accurate prognosis. A 21-year-old HIV-positive female 
presenting with clinical features of visceral leishmaniasis was enrolled in this study. Bone 
marrow cytology, Novy-MacNeal-Nicolle culture and kDNA PCR of peripheral blood were 
all positive. Typing methods, multilocus enzyme electrophoresis and ITS1-RFLP PCR of 
peripheral blood confirmed infection by Leishmania (L.) infantum chagasi. PCR has proved 
to be safer and more affordable than other characterization methods; ITS1-RFLP PCR can 
diagnose and type Leishmania spp. in both endemic and non-endemic areas, favoring the 
prognosis and allowing the appropriate treatment of patients.
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Visceral leishmaniasis (VL) caused by Leishmania (L.) infantum chagasi is a 
severe disease that takes the lives of thousands of people every year. Since the 1980s, 
the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome 
(AIDS) has increased the number of VL-HIV/AIDS coinfection cases reported in 
Europe, Africa, Asia and Latin America1,2.
Clinical diagnosis of VL-HIV/AIDS coinfection is difficult, as Leishmania 
species may initially cause non-specific clinical features in some patients, even 
when associated with epidemiological data3.
Cytological examination of spleen, bone marrow and/or lymph node stained-
smears are considered the gold standards for VL-HIV/AIDS diagnosis. Nonetheless, 
cytology may increase the risk of adverse events in patients, as invasive procedures 
are required to obtain these samples4. The culture in NNN (Novy-MacNeal-
Nicolle) medium to isolate parasites is the classical procedure recommended for 
the identification of Leishmania spp., and is essential for characterization based 
on multilocus enzyme electrophoresis (MLEE)5,6, the gold standard method for 
Leishmania spp. identification7. Nonetheless, this may require samples obtained by 
invasive procedures (e.g., spleen, bone marrow or lymph node). Moreover, culture 
may be time-consuming and difficult to perform at primary health care facilities3.
Disease control requires efficient monitoring, rapid identification of Leishmania 
strains and management of molecular tools8. Polymerase chain reaction (PCR) is 
a powerful tool for detecting Leishmania DNA in bone marrow aspirates, blood 
samples and lymph nodes and has shown to be more sensitive than parasitological 
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methods. Nowadays, there are too many targets for 
visceral leishmaniasis detection and the choice of primers 
is important because each target has its own sensitivity 
and specificity9,10. Le Fichoux et al.11 have used RV1 and 
RV2 primers to amplify kinetoplast minicircle sequences 
(kDNA), which are the most commonly used target for VL 
diagnosis. Schönian et al.12 have used LITSR and L5.8S 
primers to identify Leishmania species and the lineage of 
strains by ITS1-RFLP PCR.
The present study describes the clinical, epidemiological 
and molecular characterization of Leishmania (L.) infantum 
chagasi isolated from a visceral leishmaniasis/HIV 
coinfected patient, outlining the usefulness of the methods 
adopted here and showing which is the most affordable.
A 21-year-old HIV-positive female lived in the Agreste 
region of Northeastern Brazil, an area endemic of visceral 
leishmaniasis. She had presented with clinical features 
of visceral leishmaniasis and been referred to Hospital 
Universitário Oswaldo Cruz, Recife, in the State of 
Pernambuco. Anemia associated with anisocytosis and 
microcytosis, leukopenia with lymphopenia and neutropenia 
were the most frequent laboratory alterations found. She 
had presented with episodes of fever, splenomegaly, pale 
mucous membranes and weight loss of over 5 kg in four 
months. All these data were available in the patient’s clinical 
records. Bone marrow and peripheral blood samples were 
collected.
The aim of the study was to carry out a pioneering 
evaluation that applied a set of characterization methods 
for the detection of Leishmania spp. in an HIV-positive 
patient. Bone marrow cytology was carried out to search for 
amastigote forms by optical microscopy. In parallel, 200 µL 
of bone marrow were inoculated under sterile conditions in 
NNN culture tubes; 500 µL of NNN/Schneider two-phase 
medium were added to increase and accelerate the positivity 
of cultures. Promastigote forms were visualized by optical 
microscopy using 10 µL of culture13. The isolate was 
submitted to multilocus enzyme electrophoresis (MLEE). 
MLEE was performed with the following enzyme extracts: 
glucose-phosphate isomerase (GPI, E.C.5.3.1.9), glucose-
6-phosphate dehydrogenase (G6PDH, E.C.1.1.1.49), 
isocitrate dehydrogenase with NAD and NADP (IDHNAD 
IDHNADP, E.C.1.1.1.42) and 6-phosphogluconate 
dehydrogenase (6PGDH, E.C.1.1.1.43)7. This isolate was 
compared to reference strains of different Leishmania 
species at the Oswaldo Cruz Institute – FIOCRUZ (CLIOC/
IOC-FIOCRUZ), e.g. Leishmania (L.) infantum chagasi, 
L. braziliensis, L. guyanensis, L. shawi and L. naiff to 
determine the species.
Peripheral blood DNA extraction was carried out 
using the commercial extraction kit-illustraTM tissue 
& cells genomic Prep Mini Spin Kit (GE Healthcare, 
Buckinghamshire, UK), for the PCR methods. NanoDrop 
2000 (Thermo Scientific Nano Drop Products) was used to 
determine the DNA concentration. 
In kDNA PCR, the reaction mixture (25 µL of 
total volume) was prepared containing a buffer of 1 X 
Invitrogen, 0.25 mM dNTPs, 1.5 mM MgCl2, 2.5 units 
of Taq polymerase (Platinum®, Invitrogen, Carlsbad, 
CA), 2 µL of DNA (14 ng/µL), 25 pmol of each primer, 
RV1 (5’- CTTTTCTGGTCCCGCGGGTAGG) and RV2 
(5’- CACCTGGCCTATTTTACACCA)11, amplifying a 
conserved region of the minicircle kDNA of Leishmania. 
After an initial denaturation (5 min at 94 °C), 35 cycles 
(denaturation, 30 sec at 94 °C; annealing, 1 min at 67 °C; 
extension 30 sec at 72 °C) were performed and PCR was 
concluded by a final extension at 70 °C for 10 min. This PCR 
assay achieved a maximum analytical sensitivity of 100 fg. 
DNA amplification was performed in a LifePro thermal 
cycler (Hangzhou Bioer Technology, Binjiang, China). 
All reactions included a positive and a negative control. 
The expected final product was 145 bp. The amplification 
products were visualized by horizontal electrophoresis in 
2% ethidium bromide-stained agarose gels. 
The ITS1 PCR reaction mixture (50 µL of total volume) 
was prepared containing 25 µL 2 x GoTaq® Green Master 
Mix (Promega Corp., Madison, WI), 50 pmol of primers: 
LITSR (5’CTGGATCATTTTCCGATG) and L5.8S 
(5’ TGATACCACTTATCGCACTT)12, amplifying a portion 
of the internal transcribed spacer 1 (ITS1) non-coding region 
found in the SSU rRNA delimited by the 5.8S and 18S genes. 
After an initial denaturation (3 min at 95 °C), 35 cycles 
(denaturation, 40 sec at 95 °C; annealing, 45 sec at 53 °C; 
extension 1 min at 72 °C) were carried out and PCR was 
concluded by a final extension at 70 °C for 6 min. This PCR 
assay achieved a maximum analytical sensitivity of 100 fg. 
Reactions were performed with 2 µL (14 ng/µL), 5 µL and 
10 µL of DNA and included a positive and a negative control. 
The expected amplification product was 300-350 bp and they 
were visualized by horizontal electrophoresis in 2% ethidium 
bromide-stained agarose gels. 
Restriction enzyme analyses (RFLP) were performed in 
a total volume of 15 µL containing the ITS1 PCR product 
digested by the restriction enzyme HaeIII without prior 
purification, under the conditions recommended by the 
supplier (Hybaid GmbH Heidelberg, GE). ITS1- RFLP 
PCR was also tested on Leishmania strains from both, an 
endemic and a non-endemic area in Northeastern Brazil. 
The product underwent electrophoresis on 4.0% ethidium 
bromide-stained agarose gels. The band patterns from the 
prototypes were compared to the RFLP patterns of the 
clinical sample.
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The increasing number of visceral leishmaniasis/HIV 
coinfection cases in Brazil is worrying, in view of the 
inherent risk of developing VL when HIV is present14-16. 
Additionally, the cumulative immunosuppression 
accelerates the clinical progression of both infections17. 
In the present study, the female patient presented classical 
clinical and epidemiological features of VL infection. 
In endemic regions, where multiple species of 
Leishmania may coexist, geographical distribution may 
be an inadequate criterion. Clinical symptoms can be 
problematic for identification of the infecting species, since 
some cause both cutaneous and mucocutaneous disease (L. 
braziliensis complex, L. aethiopica), while others cause 
both visceral and cutaneous disease (e.g. L. donovani 
complex)12. 
Bone marrow cytology has variable sensitivities in both 
immunocompetent and immunosuppressed patients4,18. 
However, higher sensitivities of bone marrow cytology 
found in HIV-patients have been attributed to more intense 
Leishmania parasitemias in this group. Furthermore, the 
low number of Leishmania-infected cells in patients with 
pancytopenia, as well as those who have received previous 
treatments, may lead to false-negative results3. Bone 
marrow cytology should be requested when low sensitivity 
serological tests were performed alone, in order to avoid 
false-negative results. The patient in the present study had 
a positive bone marrow cytology. 
It is recommended to perform culture isolation of 
Leishmania in parallel with bone marrow-stained smears 
in HIV-positive patients with symptoms (e.g. fever, 
visceromegaly, or hematological abnormalities), as VL/HIV 
coinfection diagnosis is difficult3. The patient had a 
Leihmania spp. positive culture.
The allelic variation of this strain was tested using a 
panel of five enzymes by MLEE, confirming the presence 
of Leishmania (L.) infantum chagasi IOC-L 3328 (MHOM/
BR/2011/COS). One PCR target was the kinetoplast 
minicircle, which led to detection of Leishmania DNA in 
this clinical sample (data not shown). Amplification of this 
region is frequently chosen as the target for human kala-azar 
molecular diagnosis because of its higher sensitivity due 
to multi-copy number sequences9,10. PCR has consistently 
shown to be better than direct examination and culture, 
particularly in samples with low parasitic load19. Kinetoplast 
DNA PCR has been successfully used to identify Leishmania 
in blood samples of symptomatic and asymptomatic, 
immunocompetent and immunocompromised patients. 
Nevertheless, the kinetoplast is a heterogeneous target for 
which a great diversity of primers has been described and 
this may result in loss of assay accuracy, complicating the 
construction of RFLP patterns. However, it does distinguish 
a few selected species, such as L. infantum, L. donovani 
and L. major9,10,18.
The last PCR assay, targeting the ITS1 region, detected 
Leishmania DNA in a blood sample. PCR targeting the 
non-coding region found in the SSU rRNA has provided 
good results and proved to be substantially more sensitive 
than microscopic examination, especially in cases of 
HIV-coinfection10. The main advantage of ITS1 PCR 
over kDNA PCR is that the former can distinguish many 
clinically important Leishmania species through RFLP 
patterns9,12. ITS1-RFLP PCR in Leishmania trains from 
endemic and non-endemic areas in Northeastern Brazil was 
able to establish specific patterns (Figure 1). In this clinical 
sample, 2 µL (14 ng/µL) and 5 µL of DNA were insufficient 
to establish RFLP patterns after ITS1 PCR, but 10 µL did 
work (Figures 2A, 2B), thus confirming Leishmania (L.) 
infantum chagasi species.
Characterization of Leishmania spp. makes it possible 
to conduct epidemiological studies and assess the 
Leishmania population, besides targeting more accurate 
disease control measures. PCR-based methods that use 
blood samples have proved to be safer and more affordable 
than the other characterization methods mentioned above; 
especially ITS1-RFLP PCR, which can determine the levels 
of Leishmania spp. in both endemic and non-endemic 
areas favoring the prognosis and allowing the appropriate 
treatment of patients.
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Figure 1 - ITS1-RFLP PCR of different Leishmania species 
with the restriction endonuclease Hae III. M - 100 bp marker 
(Promega®); 1 - Leishmania (L.) infantum chagasi; 2 - L. 
braziliensis; 3 - L. amazonensis; 4 - L. guyanensis; 5 - L. 
mexicana; 6 - L. lainsoni; 7 - L. shawi. Specific fragments of 
Leishmania (L.) infantum chagasi are indicated by the arrow
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